ELVElevance Health, Inc.
Hospital & Medical Service Plans
- Revenue
- $199.1B
- 12% YoY
- Operating margin
- 3.6%
- 19% YoY
- EBITDA
- $7.3B
- 8.5% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 0.4×
- $2.8B net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashFired76% of net incomeCash flow under 80% of net income
- Dilutive SBCClear0% of revenueOver 10% of revenue
- Payouts exceed cash flowClear96% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear22% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $138.6B | $156.6B | $171.3B | $177.0B | $199.1B | 12% |
| Operating income | $7.6B | $8.3B | $8.5B | $7.9B | $7.2B | 8.4% |
| Net income | $6.2B | $5.9B | $6.0B | $6.0B | $5.7B | 5.3% |
| Operating cash flow | $8.4B | $8.4B | $8.1B | $5.8B | $4.3B | 26% |
| Capex | $1.1B | $1.2B | $1.3B | $1.3B | $1.1B | 11% |
| Stock-based comp | $255M | $264M | $289M | $191M | $276M | 45% |
| Buybacks | $1.9B | $2.3B | $2.7B | $2.9B | $2.6B | 10% |
| Dividends | $1.1B | $1.2B | $1.4B | $1.5B | $1.5B | 1.4% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $5M · 13
- Net
- −$5M
Pay vs performance
No pay-versus-performance disclosure yet.